Day: July 2, 2021

SAN JOSE, Calif., July 02, 2021 (GLOBE NEWSWIRE) — As part of its commitment to provide a reliable supply of safe, clean water and affordable service to the communities it serves, California Water Service (Cal Water)—the largest subsidiary of California Water Service Group (NYSE: CWT)—yesterday submitted its 2022-2024 infrastructure improvement plans for all of its California districts in its General Rate Case (GRC) filing with the California Public Utilities Commission (CPUC). The proposal also contains proposed new rate designs, which seek to balance revenue stability with reduced customer impacts, especially for low-income and water-saving customers. The CPUC will analyze the infrastructure improvement plans, operating budget proposals, and rate designs to establish water rates that reflect the actual cost of service, effective...

AB “Ignitis grupė” (hereinafter – Company) informs that on 2 July 2021 the Ministry of Finance, an authority implementing the majority shareholder’s – Republic of Lithuania, who owns 73.08 % of Company’s shares – rights  (hereinafter – Ministry of Finance) has issued an order on the amendment of the description of the Company’s Corporate Governance Guidelines (hereinafter – Corporate Governance Guidelines), approved under the order No 1k-205 of 7 June 2013 of the Minister of Finance of the Republic of Lithuania. The procedure for forming the Company’s Audit Committee has been amended in the Corporate Governance Guidelines by establishing that members of the Audit Committee will no longer be selected by the Company’s Supervisory Board, but rather by the decision of the General Meeting of Shareholders. It must be noted that after the amendments...

AB “Ignitis grupė” (hereinafter – Company) informs that on 2 July 2021 the Ministry of Finance, an authority implementing the majority shareholder’s – Republic of Lithuania, who owns 73.08 % of Company’s shares – rights  (hereinafter – Ministry of Finance) has issued an order on the amendment of the description of the Company’s Corporate Governance Guidelines (hereinafter – Corporate Governance Guidelines), approved under the order No 1k-205 of 7 June 2013 of the Minister of Finance of the Republic of Lithuania. The procedure for forming the Company’s Audit Committee has been amended in the Corporate Governance Guidelines by establishing that members of the Audit Committee will no longer be selected by the Company’s Supervisory Board, but rather by the decision of the General Meeting of Shareholders. It must be noted that after the amendments...

SAN CARLOS, Calif., July 02, 2021 (GLOBE NEWSWIRE) — Check Point® Software Technologies Ltd. (NASDAQ: CHKP), a leading provider of cyber security solutions globally, today announced that it will release its second quarter financial results for the quarter ended June 30, 2021, on Monday, July 26, 2021, before the U.S. financial markets open. Management will host a video conference call with the investment community at 8:30 AM EDT/5:30 AM PDT on July 26. A live video webcast of the call will be hosted on the company’s website at http://www.checkpoint.com/ir. To follow this and other Check Point news visit:Check Point Blog: http://blog.checkpoint.com/ Twitter: http://www.twitter.com/checkpointsw Facebook: http://www.facebook.com/checkpointsoftware YouTube: http://www.youtube.com/user/CPGlobal LinkedIn: https://www.linkedin.com/company/check-point-software-technologiesAbout...

Roche will present the final analysis from the phase IIIb STASEY study, reinforcing the safety and efficacy profile of Hemlibra in a broad range of people with haemophilia A with factor VIII inhibitors1 Spark Therapeutics will share updated data from the ongoing phase I/II clinical trial of investigational gene therapy SPK-8011, demonstrating that hepatocyte expression of factor VIII can be stable and durable up to four years following vector administration, with an acceptable safety profile2 These data reinforce Roche’s continued focus on advancing care for people living with haemophilia A and provide additional insights into the long-term efficacy and safety profile of Hemlibra, building on the results previously observed in the phase III HAVEN studiesBasel, 02 July 2021 – Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced...

LEXINGTON, Mass. and AMSTERDAM, The Netherlands, July 02, 2021 (GLOBE NEWSWIRE) — uniQure N.V. (NASDAQ: QURE), a leading gene therapy company advancing transformative therapies for patients with severe medical needs, today announced that eight data presentations, of which three are oral presentations, will be delivered at the International Society on Thrombosis and Haemostasis (ISTH) Virtual Congress being held July 17-21, 2021. Specific details on uniQure’s presentations at ISTH include:Title: Five Year Data Confirms Stable FIX Expression and Sustained Reductions in Bleeding and Factor IX Use Following AMT-060 Gene Therapy in Adults with Severe or Moderate-Severe Hemophilia B (Abstract OC 26.3)Oral Session Title: Hemostatic Agents and Hemostatic EfficacyDate and Time: Monday, July 19, 11:00 – 12:00 p.m. EDTTitle: Clinical...

Mont-Saint-Guibert, Belgium – July 2, 2021, 2:40pm CET / 8:40am ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea (OSA), today announced the pricing of its initial public offering in the United States (the “Offering”) of 2,835,000 ordinary shares at a price to the public of US$ 30 per share for total gross proceeds of US$ 85.1 million before deducting underwriting discounts and commissions and estimated offering expenses. In addition, Nyxoah has granted the underwriters a 30-day option to purchase up to an additional 425,250 ordinary shares at the initial public offering price less underwriting discounts and commissions, to cover over-allotments, if any. The closing...